Cargando…
159: Lung function changes following Sars-CoV-2 infection in cystic fibrosis
Autores principales: | Kremer, T., Onge, I. St, Trivedi, M., Dy, F., Bielick, C., Fish, D., Schaefer, O., Longtine, J., Longtine, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518456/ http://dx.doi.org/10.1016/S1569-1993(21)01584-8 |
Ejemplares similares
-
156: Pre-procedural Sars-CoV-2 testing and pulmonary function testing
por: Onge, I. St, et al.
Publicado: (2021) -
A multicenter randomized controlled clinical trial comparing central venous catheters impregnated with either 5-fluorouracil or chlorhexidine/silver sulfadiazine in preventing catheter colonization
por: Walz, JM, et al.
Publicado: (2008) -
485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease
por: Hawkins, P., et al.
Publicado: (2022) -
P135 SARS-COV-2 infection in patients with cystic fibrosis
por: Balanetchi, L., et al.
Publicado: (2021) -
51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)